Back | Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
What price did today ... | 123tom | investorshub | 07/18/2024 10:44:57 PM |
Hint it may be fish friday. | BIOChecker4 | investorshub | 07/18/2024 10:38:23 PM |
Abe, I am sorry but the Phase2b/3 Alzheimers disease | georgejjl | investorshub | 07/18/2024 10:12:19 PM |
Pros and cons for Anavex investors. | abew4me | investorshub | 07/18/2024 9:27:16 PM |
I didn't say you were old, sab. | WilliamMunny | investorshub | 07/18/2024 8:07:03 PM |
I almost believe that. | Steady_T | investorshub | 07/18/2024 8:03:10 PM |
$AVXL dropping like a rock on low volume | Investor2014 | investorshub | 07/18/2024 7:30:46 PM |
I just took out a home equity loan | mauismart | investorshub | 07/18/2024 6:34:41 PM |
There will be a zillion quad billion shares | mauismart | investorshub | 07/18/2024 6:32:39 PM |
I might be old but I think I | sab63090 | investorshub | 07/18/2024 6:25:03 PM |
Thanks for that info George. | Steady_T | investorshub | 07/18/2024 6:24:00 PM |
George: I remember you mentioning those presentations and some | sab63090 | investorshub | 07/18/2024 6:18:40 PM |
Or Denmark lol | WolfofMia | investorshub | 07/18/2024 6:17:58 PM |
Coming presentations by Anavex | georgejjl | investorshub | 07/18/2024 6:15:48 PM |
kevin Wait for Friday, not today!.....Thursday's normally not so | sab63090 | investorshub | 07/18/2024 6:13:35 PM |
There will be 4 presentations by Anavexs chief | georgejjl | investorshub | 07/18/2024 5:48:01 PM |
Traded I could understand. All bought..meh | Rubyred77 | investorshub | 07/18/2024 5:45:36 PM |
Over 5 million shares will be bought tomorrow | georgejjl | investorshub | 07/18/2024 5:34:36 PM |
Thanks George | Kdskds | investorshub | 07/18/2024 5:32:20 PM |
Expect $AVXL to close at the high of | BDR10 | investorshub | 07/18/2024 5:17:32 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer's disease patients with good comparative safety profile and no associated neuroimaging adverse events Clinical benefit of blarcamesine consistently observed for both 30 mg and 50 mg treatment groups ...
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...